Latest News
Vistra stock is growing its business, and that costs money.
Via The Motley Fool · May 7, 2025
Energy drink company Celsius (NASDAQ:CELH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.4% year on year to $329.3 million. Its non-GAAP profit of $0.15 per share was 24.1% below analysts’ consensus estimates.
Via StockStory · May 7, 2025
Online platform company Coupang (NYSE:CPNG) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 11.2% year on year to $7.91 billion. Its non-GAAP profit of $0.05 per share was in line with analysts’ consensus estimates.
Via StockStory · May 7, 2025
Benchmark increased its price target to $180 from $160, and kept a ‘Buy’ rating on EA’s shares, citing that the primary driver for the stock remains the expected launch of Battlefield in a window free of Take-Two's GTA 6.
Via Stocktwits · May 7, 2025
The US economy has emerged from the pandemic growing at a faster pace than the UK and other high-income countries.
Via Talk Markets · May 7, 2025
A Morgan Stanley survey found Americans shopping less frequently on Temu, a sign tariffs could hit the e-commerce business and PDD stock.
Via Investor's Business Daily · May 7, 2025
The analysis aims to provide valuable insights into market trends and potential opportunities.
Via Talk Markets · May 7, 2025
The semiconductor specialist initially rallied on robust results, but some on Wall Street think the future looks cloudy.
Via The Motley Fool · May 7, 2025
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET.
Via Benzinga · May 7, 2025
Performance Food Group (NYSE:PFGC) posted Q3 FY25 revenue of $15.31B, up 10.5% YoY but missing the $15.40B estimate. Growth was fueled by acquisitions, including Cheney Bros, and higher case volumes. Adjusted EPS missed at $0.79 vs. $0.87 expected. Despite strong EBITDA growth of 20.1% to $385.1M, PFGC cut the top end of its FY25 sales outlook amid inflationary pressures and higher operating costs.
Via Benzinga · May 7, 2025
Investors expect President Trump's latest order to hugely benefit this little-known stock.
Via The Motley Fool · May 7, 2025
The economic outlook is not bad if decisions on tariffs are concluded this summer. That’s true even if the tariffs end up significantly above last year’s rates.
Via Talk Markets · May 7, 2025
Via Benzinga · May 7, 2025
Zeekr shares surge as Geely proposes $6.5B privatization to streamline EV operations.
Via Benzinga · May 7, 2025
Buying Novo Nordisk stock looks like the cheapest way to invest in GLP-1 drugs.
Via The Motley Fool · May 7, 2025